Purification of the extracellular protease of Bacillus licheniformis and its inhibition by bacitracin.
AUTOR(ES)
Vitković, L
RESUMO
Sporulating cells of Bacillus licheniformis excrete three seryl proteases that are of similar size, 28,000 daltons, but of different charge at pH 6. The peptide antibiotic bactracin is released from the cells at the same time and exists, in part, as a bacitracin-protease complex that is stable throughout chromatographic procedures employed in enzyme purification. However, preextraction of crude protease with CHCl3 and subsequent gel filtration effect separation of the antibiotic and the enzyme. Three purified, bacitracin-free proteases, designated CMC I, CMC II, and CMC III and whose ratios of total activity are 1:3.7:10.3, respectively, are obtained by chromatography on carboxymethyl cellulose. The major component, CMC III, is inhibited by commercial bacitracin at near-physiological concentrations of the antibiotic.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=235546Documentos Relacionados
- Protoplast Lysis and Inhibition of Growth of Bacillus licheniformis by Bacitracin
- FORMATION OF BACITRACIN BY PROTOPLASTS OF BACILLUS LICHENIFORMIS1
- Penicillinase-releasing protease of Bacillus licheniformis: purification and general properties.
- Concomitant production of protease and lipase by Bacillus licheniformis VSG1: production, purification and characterization
- FORMATION OF BACITRACIN BY WASHED CELL SUSPENSIONS OF BACILLUS LICHENIFORMIS1
